Showing 41 - 60 results of 14,774 for search '(( via ((((linear decrease) OR (a decrease))) OR (larger decrease)) ) OR ( a latest decrease ))', query time: 0.95s Refine Results
  1. 41

    Fig 3 - by Wenping Dong (3854437)

    Published 2021
    Subjects:
  2. 42

    Fig 6 - by Wenping Dong (3854437)

    Published 2021
    Subjects:
  3. 43
  4. 44

    Image1_YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS.TIF by Jun Guo (85069)

    Published 2021
    “…<p>Lenvatinib is the latest and promising agent that has demonstrated a significant improvement of progression-free survival in advanced hepatocellular carcinoma (HCC). …”
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55

    Table 1_Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial.d... by Takeshi Osonoi (1951555)

    Published 2025
    “…</p>Results<p>The change in hemoglobin concentration at 6 months was not statistically significant (mean ± SD: −0.2 ± 0.9 g/dL; p = 0.23). While HbA1c and GA decreased and 1,5-AG increased one month after imeglimin initiation, GA and 1,5-AG showed rapid changes compared to the gradual decrease in HbA1c. …”
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60